 Synthetic Artificial Blood Vessels Market Insights, Competitive Landscape, and Market Forecast - 2033
The global Synthetic Artificial Blood Vessels Market is experiencing consistent growth as innovations in vascular surgery and biomaterials reshape the treatment landscape for cardiovascular conditi... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global Synthetic Artificial Blood Vessels Market is experiencing consistent growth as innovations in vascular surgery and biomaterials reshape the treatment landscape for cardiovascular conditions. Synthetic vascular grafts are increasingly used in bypass surgeries, hemodialysis access, and complex vascular repair procedures where natural grafts are not viable. The rising incidence of cardiovascular diseases, coupled with the growing elderly population, is significantly driving market demand. The market is projected to reach USD 470.8 million by 2033 from USD 319.4 million in 2026, expanding at a compound annual growth rate of 5.70% over the forecast period.Market Insights Synthetic artificial blood vessels are designed to replicate the functionality of natural blood vessels, offering durability and compatibility in complex surgical environments. These grafts are primarily manufactured using advanced polymers such as expanded polytetrafluoroethylene and polyethylene terephthalate, which provide strength, flexibility, and resistance to degradation. Continuous research and development efforts are focused on enhancing graft performance, reducing infection risks, and improving long-term patency rates. The increasing adoption of advanced surgical techniques and growing awareness among healthcare professionals are contributing to the steady expansion of the market. Drivers The growth of the synthetic artificial blood vessels market is largely driven by the increasing prevalence of cardiovascular diseases, including aortic aneurysms and peripheral artery disease. The rising number of surgical interventions requiring vascular grafts has significantly boosted product demand. Additionally, the growing incidence of chronic kidney disease has led to higher usage of synthetic grafts in hemodialysis procedures. Technological advancements in biomaterials and polymer science have improved the safety and effectiveness of synthetic grafts, encouraging their widespread adoption. The limited availability of suitable autologous vessels for grafting further supports the shift toward synthetic alternatives. Moreover, the expanding geriatric population, which is more prone to vascular complications, is creating sustained demand for these devices. Increasing healthcare investments and improved accessibility to advanced treatment options in developing regions are also contributing to market growth. Business Opportunity The market offers promising opportunities for manufacturers and researchers focusing on innovation. The development of bioengineered vascular grafts that closely mimic natural tissue is gaining momentum, with significant investments directed toward regenerative medicine and tissue engineering. Hybrid graft technologies that integrate synthetic materials with biological components are expected to redefine treatment outcomes. There is also growing interest in incorporating nanotechnology and advanced surface modification techniques to enhance graft compatibility and reduce complications. Emerging economies, particularly in Asia Pacific and Latin America, present substantial growth potential due to expanding healthcare infrastructure and rising patient awareness. Strategic partnerships between medical device companies and research institutions are likely to accelerate product development and market penetration. Additionally, the increasing adoption of minimally invasive procedures is driving demand for specialized graft solutions tailored to modern surgical techniques. Region Analysis North America remains the leading region in the synthetic artificial blood vessels market, supported by a well-established healthcare system, high prevalence of cardiovascular disorders, and strong presence of key industry players. The region also benefits from extensive research activities and favorable reimbursement policies. Europe holds a significant share of the market, driven by advancements in medical technology and increasing adoption of innovative surgical procedures. Countries such as Germany, France, and the United Kingdom are contributing to regional growth through continuous investment in healthcare and research. Asia Pacific is expected to witness the fastest growth during the forecast period, fueled by rapid urbanization, increasing healthcare expenditure, and rising awareness of cardiovascular health. Growing patient populations in countries like China, India, and Japan are driving demand for advanced vascular treatments. Latin America and the Middle East & Africa are gradually emerging as important markets. Improvements in healthcare infrastructure and government initiatives aimed at enhancing medical access are supporting growth, although certain regions still face challenges related to limited healthcare resources. Key Players • B. Braun Melsungen AG • Terumo Aortic (Terumo Group) • Humacyte, Inc. • LeMaitre Vascular, Inc. • W. L. Gore and Associates • JOTEC GmbH • Cook Medical Inc. • Bard Peripheral Vascular Segmentation By Polymer • Expanded polytetrafluoroethylene (ePTFE) • Polyethylene Terephthalate • Polyurethane • Others By Application • Aortic Disease • Hemodialysis • Peripheral Artery Disease By End User • Hospitals • Cardiac Catheterization Laboratories • Ambulatory Surgical Centers • Specialty Clinics By Geography • North America • Europe • Asia Pacific • Latin America • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Synthetic Artificial Blood Vessels Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global Synthetic Artificial Blood Vessels Market Outlook, 2020-2033 3.1. Global Synthetic Artificial Blood Vessels Market Outlook, by Polymer, Value (US$ Mn), 2020-2033 3.1.1. Expanded polytetrafluoroethylene (ePTFE) 3.1.2. Polyethylene Terephthalate 3.1.3. Polyurethane 3.1.4. Others 3.2. Global Synthetic Artificial Blood Vessels Market Outlook, by Application, Value (US$ Mn), 2020-2033 3.2.1. Aortic Disease 3.2.2. Hemodialysis 3.2.3. Peripheral Artery Disease 3.3. Global Synthetic Artificial Blood Vessels Market Outlook, by End user, Value (US$ Mn), 2020-2033 3.3.1. Hospitals 3.3.2. Cardiac Catheterization Laboratories 3.3.3. Ambulatory Surgical Centers 3.3.4. Specialty Clinics 3.4. Global Synthetic Artificial Blood Vessels Market Outlook, by Region, Value (US$ Mn), 2020-2033 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Latin America 3.4.5. Middle East & Africa 4. North America Synthetic Artificial Blood Vessels Market Outlook, 2020-2033 4.1. North America Synthetic Artificial Blood Vessels Market Outlook, by Polymer, Value (US$ Mn), 2020-2033 4.1.1. Expanded polytetrafluoroethylene (ePTFE) 4.1.2. Polyethylene Terephthalate 4.1.3. Polyurethane 4.1.4. Others 4.2. North America Synthetic Artificial Blood Vessels Market Outlook, by Application, Value (US$ Mn), 2020-2033 4.2.1. Aortic Disease 4.2.2. Hemodialysis 4.2.3. Peripheral Artery Disease 4.3. North America Synthetic Artificial Blood Vessels Market Outlook, by End user, Value (US$ Mn), 2020-2033 4.3.1. Hospitals 4.3.2. Cardiac Catheterization Laboratories 4.3.3. Ambulatory Surgical Centers 4.3.4. Specialty Clinics 4.4. North America Synthetic Artificial Blood Vessels Market Outlook, by Country, Value (US$ Mn), 2020-2033 4.4.1. U.S. Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 4.4.2. U.S. Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 4.4.3. U.S. Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 4.4.4. Canada Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 4.4.5. Canada Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 4.4.6. Canada Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 4.5. BPS Analysis/Market Attractiveness Analysis 5. Europe Synthetic Artificial Blood Vessels Market Outlook, 2020-2033 5.1. Europe Synthetic Artificial Blood Vessels Market Outlook, by Polymer, Value (US$ Mn), 2020-2033 5.1.1. Expanded polytetrafluoroethylene (ePTFE) 5.1.2. Polyethylene Terephthalate 5.1.3. Polyurethane 5.1.4. Others 5.2. Europe Synthetic Artificial Blood Vessels Market Outlook, by Application, Value (US$ Mn), 2020-2033 5.2.1. Aortic Disease 5.2.2. Hemodialysis 5.2.3. Peripheral Artery Disease 5.3. Europe Synthetic Artificial Blood Vessels Market Outlook, by End user, Value (US$ Mn), 2020-2033 5.3.1. Hospitals 5.3.2. Cardiac Catheterization Laboratories 5.3.3. Ambulatory Surgical Centers 5.3.4. Specialty Clinics 5.4. Europe Synthetic Artificial Blood Vessels Market Outlook, by Country, Value (US$ Mn), 2020-2033 5.4.1. Germany Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 5.4.2. Germany Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 5.4.3. Germany Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 5.4.4. Italy Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 5.4.5. Italy Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 5.4.6. Italy Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 5.4.7. France Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 5.4.8. France Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 5.4.9. France Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 5.4.10. U.K. Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 5.4.11. U.K. Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 5.4.12. U.K. Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 5.4.13. Spain Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 5.4.14. Spain Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 5.4.15. Spain Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 5.4.16. Russia Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 5.4.17. Russia Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 5.4.18. Russia Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 5.4.19. Rest of Europe Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 5.4.20. Rest of Europe Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 5.4.21. Rest of Europe Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 5.5. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Synthetic Artificial Blood Vessels Market Outlook, 2020-2033 6.1. Asia Pacific Synthetic Artificial Blood Vessels Market Outlook, by Polymer, Value (US$ Mn), 2020-2033 6.1.1. Expanded polytetrafluoroethylene (ePTFE) 6.1.2. Polyethylene Terephthalate 6.1.3. Polyurethane 6.1.4. Others 6.2. Asia Pacific Synthetic Artificial Blood Vessels Market Outlook, by Application, Value (US$ Mn), 2020-2033 6.2.1. Aortic Disease 6.2.2. Hemodialysis 6.2.3. Peripheral Artery Disease 6.3. Asia Pacific Synthetic Artificial Blood Vessels Market Outlook, by End user, Value (US$ Mn), 2020-2033 6.3.1. Hospitals 6.3.2. Cardiac Catheterization Laboratories 6.3.3. Ambulatory Surgical Centers 6.3.4. Specialty Clinics 6.4. Asia Pacific Synthetic Artificial Blood Vessels Market Outlook, by Country, Value (US$ Mn), 2020-2033 6.4.1. China Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 6.4.2. China Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 6.4.3. China Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 6.4.4. Japan Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 6.4.5. Japan Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 6.4.6. Japan Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 6.4.7. South Korea Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 6.4.8. South Korea Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 6.4.9. South Korea Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 6.4.10. India Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 6.4.11. India Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 6.4.12. India Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 6.4.13. Southeast Asia Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 6.4.14. Southeast Asia Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 6.4.15. Southeast Asia Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 6.4.16. Rest of SAO Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 6.4.17. Rest of SAO Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 6.4.18. Rest of SAO Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 6.5. BPS Analysis/Market Attractiveness Analysis 7. Latin America Synthetic Artificial Blood Vessels Market Outlook, 2020-2033 7.1. Latin America Synthetic Artificial Blood Vessels Market Outlook, by Polymer, Value (US$ Mn), 2020-2033 7.1.1. Expanded polytetrafluoroethylene (ePTFE) 7.1.2. Polyethylene Terephthalate 7.1.3. Polyurethane 7.1.4. Others 7.2. Latin America Synthetic Artificial Blood Vessels Market Outlook, by Application, Value (US$ Mn), 2020-2033 7.2.1. Aortic Disease 7.2.2. Hemodialysis 7.2.3. Peripheral Artery Disease 7.3. Latin America Synthetic Artificial Blood Vessels Market Outlook, by End user, Value (US$ Mn), 2020-2033 7.3.1. Hospitals 7.3.2. Cardiac Catheterization Laboratories 7.3.3. Ambulatory Surgical Centers 7.3.4. Specialty Clinics 7.4. Latin America Synthetic Artificial Blood Vessels Market Outlook, by Country, Value (US$ Mn), 2020-2033 7.4.1. Brazil Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 7.4.2. Brazil Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 7.4.3. Brazil Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 7.4.4. Mexico Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 7.4.5. Mexico Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 7.4.6. Mexico Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 7.4.7. Argentina Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 7.4.8. Argentina Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 7.4.9. Argentina Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 7.4.10. Rest of LATAM Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 7.4.11. Rest of LATAM Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 7.4.12. Rest of LATAM Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 7.5. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Synthetic Artificial Blood Vessels Market Outlook, 2020-2033 8.1. Middle East & Africa Synthetic Artificial Blood Vessels Market Outlook, by Polymer, Value (US$ Mn), 2020-2033 8.1.1. Expanded polytetrafluoroethylene (ePTFE) 8.1.2. Polyethylene Terephthalate 8.1.3. Polyurethane 8.1.4. Others 8.2. Middle East & Africa Synthetic Artificial Blood Vessels Market Outlook, by Application, Value (US$ Mn), 2020-2033 8.2.1. Aortic Disease 8.2.2. Hemodialysis 8.2.3. Peripheral Artery Disease 8.3. Middle East & Africa Synthetic Artificial Blood Vessels Market Outlook, by End user, Value (US$ Mn), 2020-2033 8.3.1. Hospitals 8.3.2. Cardiac Catheterization Laboratories 8.3.3. Ambulatory Surgical Centers 8.3.4. Specialty Clinics 8.4. Middle East & Africa Synthetic Artificial Blood Vessels Market Outlook, by Country, Value (US$ Mn), 2020-2033 8.4.1. GCC Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 8.4.2. GCC Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 8.4.3. GCC Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 8.4.4. South Africa Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 8.4.5. South Africa Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 8.4.6. South Africa Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 8.4.7. Egypt Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 8.4.8. Egypt Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 8.4.9. Egypt Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 8.4.10. Nigeria Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 8.4.11. Nigeria Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 8.4.12. Nigeria Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 8.4.13. Rest of Middle East Synthetic Artificial Blood Vessels Market Outlook, by Polymer, 2020-2033 8.4.14. Rest of Middle East Synthetic Artificial Blood Vessels Market Outlook, by Application, 2020-2033 8.4.15. Rest of Middle East Synthetic Artificial Blood Vessels Market Outlook, by End user, 2020-2033 8.5. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. B. Braun Melsungen AG 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. Terumo Aortic (Terumo Group) 9.4.3. Humacyte, Inc. 9.4.4. LeMaitre Vascular, Inc. 9.4.5. W. L. Gore and Associates 9.4.6. JOTEC GmbH 9.4.7. Cook Medical Inc. 9.4.8. Bard Peripheral Vascular 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
Fairfield Market Research社の 医療機器分野 での最新刊レポート
本レポートと同じKEY WORD（artificial）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
